4//SEC Filing
VAGELOS P ROY 4
Accession 0001883850-22-000020
CIK 0000872589other
Filed
Mar 14, 8:00 PM ET
Accepted
Mar 15, 4:01 PM ET
Size
11.8 KB
Accession
0001883850-22-000020
Insider Transaction Report
Form 4
VAGELOS P ROY
Director
Transactions
- Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2022-03-14−75,000→ 0 totalExercise: $179.13Exp: 2022-12-14→ Common Stock (75,000 underlying) - Tax Payment
Common Stock
2022-03-14$655.29/sh−48,103$31,521,415→ 345,566 total - Exercise/Conversion
Common Stock
2022-03-14$179.13/sh+75,000$13,434,750→ 393,669 total - Gift
Common Stock
2022-01-04−338→ 141,292 total(indirect: by CLAT)
Holdings
- 37,747(indirect: By Trust)
Common Stock
- 3,609(indirect: By Trust)
Common Stock
- 2,096(indirect: By 401(k))
Common Stock
Footnotes (2)
- [F1]By trusts for the benefit of nine grandchildren of the reporting person, each of which holds 401 shares of Company stock. The reporting person and/or the spouse of the reporting person is the trustee of each such trust.
- [F2]The stock option award vests in four equal annual installments, commencing one year after the date of grant.
Documents
Issuer
REGENERON PHARMACEUTICALS, INC.
CIK 0000872589
Entity typeother
IncorporatedMD
Related Parties
1- filerCIK 0001013064
Filing Metadata
- Form type
- 4
- Filed
- Mar 14, 8:00 PM ET
- Accepted
- Mar 15, 4:01 PM ET
- Size
- 11.8 KB